biopsy considerations after progression in alk nsclc
Published 5 years ago • 59 plays • Length 4:08Download video MP4
Download video MP3
Similar videos
-
4:39
biopsy considerations after progression in alk nsclc
-
6:51
progression in alk nsclc after frontline therapy
-
6:04
case study: progression on alk inhibitors in nsclc
-
8:42
rebiopsy and acquired mutations following progression in non-small cell lung cancer
-
4:31
emerging applications of liquid biopsy in non-small-cell lung cancer
-
3:55
treatment considerations in alk/ros-1–rearranged nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
2:08
resistance mechanisms in alk-rearranged nsclc
-
1:19
dr. dimou on managing disease progression in nsclc
-
0:56
dr. stinchcombe on the alta-1l trial in alk nsclc
-
5:49
various forms of disease progression in advanced nsclc
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
3:28
treatment after progression in advanced-stage nsclc
-
1:57
dr. shaw on sequencing strategies in alk-positive nsclc
-
9:53
sequencing therapy in alk nsclc
-
4:13
repeat mutation testing at alk-rearranged nsclc progression
-
0:39
continuation of ceritinib beyond disease progression in alk-positive nsclc
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc